User:Mr. Ibrahem/Retapamulin

Retapamulin, sold as the brand name Altabax among others, is a antibiotic which is applied to the skin to threat impetigo, a bacterial skin infection. It is not useful against MRSA.

Common side effects include irritation at the site it is used. Other side effects may include allergic reactions such as angioedema. It generally works by stopping bacterial growth by inhibiting the bacterial ribosome.

Retapamulin was approved for medical use in the United States and Europe in 2007. It; however, was withdrawn from the market in 2019 in Europe. In the United States 15 grams of 1% cream costs about 325 USD as of 2021. It was original made from a fungus.